BEVERLY UHLENHAKE: Open Payments
NPI 1023018942 · FORT RECOVERY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 31 payments from 8 companies in 2025. Trend: 2023 $290 · 2024 $728 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $313 |
| Lilly USA, LLC | 4 | $93 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| ABBVIE INC. | 1 | $70 |
| PFIZER INC. | 4 | $60 |
| Novo Nordisk Inc | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| ACADIA Pharmaceuticals Inc | 1 | $15 |
Products named: FARXIGA, AIRSUPRA, MOUNJARO, LEQVIO, VRAYLAR, NURTEC ODT, Ozempic, Auvelity.
Industry payments across OH — which companies pay providers there.
